Inactive Instrument
Immune Pharmaceuticals, Inc. Stock
Stocks
FZRQ
US45254C2008
Pharmaceuticals
OTC Markets Traded| 1 day | +300.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Devin J. Shaw
DFI | Director of Finance/CFO | 39 | 2021-04-12 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 2017-12-10 |
Boris Shor
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Sidransky
BRD | Director/Board Member | 66 | 2013-08-25 |
Daniel Kazado
CHM | Chairman | 61 | 2013-10-09 |
John A. Neczesny
BRD | Director/Board Member | 62 | 2016-02-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/3/20 | Sell | Director | 75,000 | 0.0412% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +300.00% | -.--% | - | - | 386K | |
| +1.30% | -0.76% | +54.90% | +163.81% | 1,043B | |
| +1.21% | -1.05% | +56.02% | +59.85% | 602B | |
| +1.40% | +3.83% | +34.57% | +91.03% | 449B | |
| +0.59% | -0.74% | +30.00% | +24.57% | 327B | |
| +0.88% | +0.08% | +33.25% | +46.47% | 279B | |
| -0.40% | -2.18% | +21.74% | +23.08% | 264B | |
| +0.08% | +2.67% | +25.10% | +63.76% | 201B | |
| +1.15% | +6.65% | +27.27% | +78.72% | 169B | |
| +0.74% | +4.94% | +3.19% | -29.27% | 143B | |
| Average | +30.75% | -0.68% | +31.78% | +58.00% | 386.34B | |
| Weighted average by Cap. | +1.05% | -1.82% | +40.68% | +85.34% |
Employees
7
Sector
Pharmaceuticals
Choose MarketScreener 
